Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Reexamination Certificate
2002-02-22
2004-09-07
Badio, Barbara P. (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
C514S731000, C514S846000, C514S848000
Reexamination Certificate
active
06787148
ABSTRACT:
TECHNICAL FIELD
The present invention relates to a chemically peeling agent adapted to remove wrinkles, spots (pigmentation such as geriatric pigment spots) and a somber color on the skin, to treat pimples, and to improve a greasy skin. The term “chemically peeling agent” referred to in this description is intended to mean a chemically peeling agent for use as medicine or cosmetics.
In the West, removal of wrinkles, spots and so on is considered as one of methods for medical treatments. A treatment method that is generally adopted at hospitals of dermatology, orthopedics, or cosmetic surgery in the western countries, involves pasting the skin with an aqueous solution of different concentrations of a chemically peeling agent, including trichloroacetic acid (TCA), phenol and so on, for an appropriate duration of time to artificially make a chemical burn (corrosion) and thereafter to reproduce normal cells on the skin in a natural way.
This treatment with such chemically peeling agents, however, is effective for white people, it may cause the skin of Asian people problems with side effects including red spots, pigmentation, scars and so on after operation.
Recently, it has been found that &agr;-hydroxy acid (AHA) is relatively safe and it is effective for the peeling treatment for Asian people. This treatment has now been conducted as a general treatment method. The effects and the side effects to be produced by this method, however, greatly depend upon the concentration and pH of AHA, so that it suffers from the difficulty that this treatment method requires experienced skills.
More recently, the treatment with a solution of salicylic acid in an alcohol has been adopted in the U.S. and it has been found to be effective for white people. This treatment method, however, causes Asian people problems with severe side effects including, for example, flare or pain during treatment and pigmentation after treatment.
As a result of extensive and long-lasting research, it was found by the present inventor that, although an agent containing salicylic acid in polyethylene glycol cannot be absorbed through the skin so that it has been considered to be ineffective for the treatment of skin diseases, a mixture of salicylic acid with polyethylene glycol allows salicylic acid to be sustained in the polyethylene glycol and retained in the horny layer without penetrating into a sebaceous matter at a high concentration and to strongly peel off the horny layer only without causing any systemic side effects. Further, it was found that a mixture of a phenol compound, such as phenol or resorcinol, with a polyethylene glycol or an equivalent compound could exhibit the effects similar to the mixture of salicylic acid with the polyethylene glycol.
The present invention has been completed on the basis of these findings and has the object to provide a chemically peeling agent that does not cause any side effects including red spots, pigmentation and scars after operation, refreshes the skin (removing fine wrinkles and providing the skin with flexibility), removes spots, and improve a somber color on the skin. Further, the chemically peeling agent can treat pimples and improve a greasy skin.
DISCLOSURE OF INVENTION
In order to achieve the object as described above, the present invention provides a chemically peeling agent comprising a component (A) having the following general formula:
B&Brketopenst;&Parenopenst;CH
2
CH
2
O)
m
(AO)
n
−-H]
a
(wherein B is an alcohol residue;
AO is an alkylene-oxy group having 3 to 18 carbon atoms;
a is an integer of 1 or more;
m is an integer of 4 or more; and
n is 0 or an integer of 1 or more;
provided that a molar amount
m
of the oxidized ethylene to be added is a value that amounts to 40% or more of the entire molecular weight of an ethylene oxide chain moiety)
and a phenol compound (B) formulated in an amount ranging from 10% to 30% by weight.
The component (A) to be used for the present invention may be represented by the above general formula.
In the above general formula, the alcohol to be represented by reference symbol B is intended to mean a mono-valent alcohol Including, for example, an alkyl alcohol such as methanol, ethanol, butanol, lauryl alcohol, myristyl alcohol, palmityl alcohol, stearyl alcohol, cetyl alcohol, etc., and an alkenyl alcohol such as linoleyl alcohol, palmitoyl alcohol, oleyl alcohol, etc., a di-valent alcohol such as ethylene glycol, propylene glycol, etc., a tri-valent alcohol such as glycerin, trimethylol propane, triethanol amine, etc., a tetra-valent alcohol such as pentaerythritol, diglycerin, etc. There may also be used other poly-valent alcohols such as sorbitol, polyglycerin and so on.
The alkylene-oxy group having 3 to 18 carbon atoms, as referred to by reference symbol AO, may include, for example, propylene-oxy, butylene-oxy, tetrahydrofuran, &agr;-olefin-oxy, and so on. The alkylene-oxy groups having 3 and 4 carbon atoms, such as oxido-propylene, oxido-butylene and tetrahydrofuran, are preferred.
In the above general formula, reference symbol “a” is an integer of 1 or more. When the alcohol to be used for the present invention is a mono-valent alcohol, the reference symbol “a” is 1. When the alcohol to be used therefor is a di-valent alcohol, the reference symbol “a” is 2. Likewise, when the alcohol to be used therefor is a tri-valent alcohol, the reference symbol “a” is 3. Further, when the alcohol to be used therefor is a poly-valent alcohol, the reference symbol “a” is the integer corresponding to the valence of the alcohol used.
In the above general formula, reference symbol “m” is intended to mean an average molar amount of ethylene oxide to be added. The number of a polymerization chain of the ethylene oxide has to be at least 4.
Reference symbol “n” is intended to mean an average molar amount of an oxidized alkylene to be added. The number of a polymerization chain of the oxidized alkylene is zero or 1 or more.
The manner of polymerization of the ethylene oxide and the alkylene oxide is random or block polymerization.
The molar amount
m
of the ethylene oxide to be added is set to amount to 40% or more of the entire molecular weight of the ethylene oxide chain. This setting is based on the fact that, if the molar amount
m
of the ethylene oxide to be added would be less than the above molar amount, the phenol compound such as salicylic acid would become unlikely to be sustained in the polyethylene glycol derivative.
The component (A) may be synthesized in a conventional manner, for example, by reacting the ethylene oxide and the alkylene oxide with the alkyl alcohol or the alkenyl alcohol under an inert gas such as nitrogen or the like in the presence of a basic catalyst such as sodium hydroxide, potassium hydroxide or the like or an acidic catalyst such as boron tetrafluoride, tin tetrachloride or the like.
Specific examples of the compounds (A) may include, for example, a polyethylene glycol and a derivative thereof, a polyoxyethylene polyoxypropylene glycol and a derivative thereof, and a polyoxyethylene long-chain alkyl ether and a polyoxyethylene long-chain alkenyl ether to be used as a non-ionic surfactant. Among these examples, the polyethylene glycol is listed as trade name “Macrogol” in the Japanese Pharmacopoeia and the Regulations of Medicinal Additives. Likewise, a block copolymer of ethylene oxide or propylene oxide is listed as a poloximer therein. The phenol compound to be added as the main component can be sustained in those compounds and retained in the horny layer without penetrating into a sebaceous matter at a high concentration. Therefore, these compounds can preferably be used because they have no risk of causing any systemic side effects and can peel only the horny layer off. These compounds can be used singly or in combination of two or more.
As the phenol compound (B) to be used for the present invention, there may be mentioned phenol, resorcinol, salicylic acid and so on.
Among the phenol compounds (B), salicylic acid is preferred. The phenol compounds may be used singly or in combin
Ueda Kaori
Ueda Setsuko
Badio Barbara P.
Jordan and Hamburg LLP
LandOfFree
Chemical peeling agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical peeling agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical peeling agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3233547